FindTrial
Sign In

Retrospective analysis of monoclonal antibody drug utilization and clinical rational drug use in a tertiary A hospital

Retrospective analysis on the utilization status of monoclonal antibody drugs and clinical rational drug use in a tertiary A hospital from 2018 to 2021

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059572
Enrollment
Unknown
Registered
2022-05-04
Start date
2022-05-02
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

case series:None

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 15-90 years. 2. Patients with confirmed cancer who have received monoclonal antibodies and have been histologically or cytologically confirmed. 3. kps score over 70.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Drug dose;Adverse events;—

Countries

China

Contacts

Public ContactWang Guojun
wanggj7532@163.com+86 15283005000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026